We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+22.69%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.54B
AUM Growth
+$250M
Cap. Flow
+$10.9M
Cap. Flow %
0.71%
Top 10 Hldgs %
26%
Holding
2,766
New
315
Increased
751
Reduced
946
Closed
559

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Healthcare 14.71%
3 Consumer Discretionary 11.46%
4 Financials 8.68%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOD icon
801
Kodiak Sciences
KOD
$2.84B
$83K 0.01%
1,547
+465
+43% +$26.2K
ADUS icon
802
Addus HomeCare
ADUS
$2.24B
$82K 0.01%
882
+874
+10,925% +$75.6K
KURA icon
803
Kura Oncology
KURA
$844M
$82K 0.01%
5,029
+4,619
+1,127% +$66.6K
CMS icon
804
CMS Energy
CMS
$22.3B
$81K 0.01%
1,395
-146
-9% -$8.45K
HIG icon
805
Hartford Financial Services
HIG
$39.3B
$81K 0.01%
2,093
-16,439
-89% -$626K
OKTA icon
806
Okta
OKTA
$25.8B
$81K 0.01%
398
+5
+1% +$849
YMAB
807
DELISTED
Y-mAbs Therapeutics
YMAB
$81K 0.01%
1,867
+1,454
+352% +$55K
DAL icon
808
Delta Air Lines
DAL
$60.2B
$80K 0.01%
2,867
-16,863
-85% -$429K
DCI icon
809
Donaldson
DCI
$11.4B
$80K 0.01%
1,708
+1,320
+340% +$58.4K
EVRG icon
810
Evergy
EVRG
$19.3B
$80K 0.01%
1,350
-70,735
-98% -$4.19M
NTLA icon
811
Intellia Therapeutics
NTLA
$1.65B
$80K 0.01%
3,860
+3,753
+3,507% +$63.8K
PGRE
812
DELISTED
Paramount Group
PGRE
$80K 0.01%
10,269
-1,642
-14% -$13.9K
RICK icon
813
RCI Hospitality Holdings
RICK
$217M
$80K 0.01%
5,853
+3,504
+149% +$42.8K
LNT icon
814
Alliant Energy
LNT
$18.1B
$79K 0.01%
1,656
-18,754
-92% -$913K
UNIT
815
Uniti Group
UNIT
$2.31B
$78K 0.01%
8,386
VRSN icon
816
VeriSign
VRSN
$26.5B
$78K 0.01%
378
+147
+64% +$30.5K
WTW icon
817
Willis Towers Watson
WTW
$32B
$78K 0.01%
398
+316
+385% +$60.5K
CNST
818
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$78K 0.01%
2,593
+1,912
+281% +$68.9K
CHRS icon
819
Coherus Oncology
CHRS
$210M
$77K 0.01%
4,253
-2,712
-39% -$45.9K
RARE icon
820
Ultragenyx Pharmaceutical
RARE
$2.52B
$77K 0.01%
973
+868
+827% +$57.5K
RWT
821
Redwood Trust
RWT
$592M
$77K 0.01%
+10,996
New +$54.2K
SJM icon
822
J.M. Smucker
SJM
$12.9B
$77K 0.01%
731
-299
-29% -$33.6K
SPY icon
823
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$77K 0.01%
249
-955
-79% -$280K
MTEM
824
DELISTED
Molecular Templates, Inc.
MTEM
$77K 0.01%
371
+109
+42% +$25.3K
BALL icon
825
Ball Corp
BALL
$16.8B
$76K ﹤0.01%
1,100
+969
+740% +$65.5K

Similar funds

Meeder Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Meeder Asset Management held 2,766 positions worth $1.54B, up 19% from $1.29B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Meeder Asset Management's Q2 2020 filing shows 315 new, 751 increased, 946 reduced and 559 closed positions. Its largest new stake was Boise Cascade: 20,014 shares worth $754K. The largest sale was Vanguard Short-Term Bond ETF, an estimated $20.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Meeder Asset Management's largest Q2 2020 buy was Boise Cascade: 20,014 shares worth $754K.
  • Meeder Asset Management added most to Xtrackers USD High Yield Corporate Bond ETF in Q2 2020, an estimated $39.6M increase.
  • Meeder Asset Management's biggest Q2 2020 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $20.8M.
  • Meeder Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $3.9M.
  • Meeder Asset Management's ten largest holdings make up 26% of its $1.54B portfolio in Q2 2020.
  • Meeder Asset Management opened 315 new positions and closed 559 in Q2 2020.
  • Meeder Asset Management's portfolio value rose 19% quarter-over-quarter to $1.54B.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.